Latest News

Journal Articles

Autoimmune

Could hyaluronic acid contribute to chronic white matter injury?

Can living in a sunnier climate in your youth reduce the risk of MS?

Could transcranial direct current stimulation offer relief from fatigue in multiple sclerosis sufferers?

Cerebrovascular disease

Traumatic microbleeds may predict worse outcomes following head injury

Blood pressure changes in mid-30s linked to poorer brain health

Age-related cognitive changes may be reduced with intensive blood pressure control

CNS/PNS/SNS

Neuroprosthetic exoskeleton allows tetraplegic patient to utilize his limbs

Traumatic CNS injury and the inflammatory stem cell niche: an interview with Aileen Anderson

Electrical patterns in ‘mini-brains’ can’t be distinguished from premature babies, study reveals

Cognitive/neurodegenerative disorders

Deactivating microglia reduces tau-linked brain damage in mice, study reveals

Signs of dementia may be detected earlier in women with new diagnostic criteria

Can choline reduce Alzheimer’s-related symptoms in female mice?

Demyelinating disease

Unraveling the heterogeneity of oligodendrocytes with Ana Mendanha Falcão

Acquiring viable astrocytes and microglia from adult brain tissue: an interview with Pascale Eede & Verena Haage

Physician and patient treatment decision-making in relapsing–remitting multiple sclerosis in Europe and the USA

Development and pediatrics

Researchers discover molecular process that may hold potential to accelerate nerve injury recovery in mice

A new perspective on the development of neural circuits in embryos

Researchers challenge the ‘extreme male brain’ theory of autism

Epilepsy and seizure

Epidyolex® receives marketing authorization from the EMA for seizures

Ponesimod hits key endpoints in clinical trial for relapsing multiple sclerosis: industry news round-up

WHO releases first global report on epilepsy

Genetics

Genetic therapies for neurodegenerative diseases: an interview with Sarah Tabrizi

Brain architecture linked to genetic regions in left-handed people

Could how much you sleep depend on your genes?

Headache

Emgality® achieves primary and secondary outcomes in Phase III trial for migraines

Acute migraine: novel therapy shows promise in Phase III trial

Why are migraines more common in women? New sex-specific insights revealed

Immune disorders and inflammation

Inflammatory disease and anxiety: could endocannabinoids be a mechanism of comorbidity?

FENS 2018: Immune system offers new way of treating Alzheimer’s disease

FENS 2018: Could anxiety and inflammation be treated with cannabis?

Infection

Could a bacterial polysaccharide suppress fatal brain inflammation?

Link between Alzheimer’s disease and periodontal bacteria gains traction

ANA 2018: key highlights and news stories

Injury/trauma

Tranexamic acid could reduce head injury deaths by ‘hundreds of thousands’

Traumatic microbleeds may predict worse outcomes following head injury

Traumatic CNS injury and the inflammatory stem cell niche: an interview with Aileen Anderson

Movement disorders

Neuroprosthetic exoskeleton allows tetraplegic patient to utilize his limbs

Parkinson’s progression could be slowed down by drug that treats enlarged prostate

Ofatumumab demonstrates superiority over Aubagio® for relapsing MS: industry news round-up

Neuro-ophthalmology

Gene therapy breakthrough allows mice to regain sight

Could an eye scan detect signs of Alzheimer's disease?

Vision in Alzheimer's disease: a focus on the anterior afferent pathway

Neurometabolic

Epigenetics, opioids and immune regulation: interviews from SfN17

Jeffrey Iliff: glymphatics, Alzheimer’s and future directions

SfN17: Neurodegeneration and the microbiome – new research highlights

Neuromuscular

Ataluren use in nonsense mutation Duchenne muscular dystrophy: patient information from the STRIDE Registry

New genetic suspects identified for ALS and FTD

Novel discovery in motor neuron disease may pave the way for future treatments

Neuropsychiatry

World Mental Health Day: facts, figures and the flaws of academia

Could psychiatric disorders be triggered by air pollution?

Addiction: a compulsive interplay between drugs, cues and habits

Oncology/tumor

High-grade gliomas may hijack signals from neurons to drive their own growth

Glioblastoma: could a blood test be on the horizon?

Veledimex: a drug-inducible gene therapy approach for glioblastoma yields promising Phase I results

Pain

Emgality® achieves primary and secondary outcomes in Phase III trial for migraines

Advances in migraine genetics, neurobiology and treatment

Acute migraine: novel therapy shows promise in Phase III trial

Sleep

Could circadian rhythms influence immune response efficiency in mice?

Could how much you sleep depend on your genes?

Acute light exposure at night doesn’t affect circadian rhythm in mice, research suggests